Counterfeit weight-loss injections and fake painkillers linked to criminal gangs have entered Denmark, with authorities confirming at least one death and Novo Nordisk reporting seven deaths worldwide from falsified GLP-1 products.
Court cases against biker groups now show that fake prescription medicines have moved from overseas warehouses into Danish streets. TV2 Business uncovered evidence in May 2026 that counterfeit slimming pens are circulating here, sold through the same networks that traffic opioids and doping agents. The Danish Health Authority confirmed a death this year from nitazene poisoning after someone took what looked like legitimate OxyContin tablets. South Jutland police warned publicly in April 2025 about fake OxyContin blister packs containing etonitazene, a synthetic opioid more potent than fentanyl.
This is not just a Danish problem, but Denmark is no longer sheltered from it. Novo Nordisk has documented seven deaths, 99 hospitalisations and 319 serious adverse events globally tied to illegal copies of its Wegovy and Ozempic products. Some fake pens contain the wrong dose or no active ingredient at all. Others are filled with insulin or completely different drugs. For expats navigating long waiting lists and strict eligibility rules, the temptation to buy weight-loss medication online or through friends can be strong.
The criminal supply chain
As noted by Danish court documents, rocker and gang networks are now treating high-value prescription drugs as a revenue stream. One 40-year-old man in Region Syddanmark was sentenced to 15 months in prison for defrauding the region of over one million kroner by forging prescriptions for weight-loss medicine and reselling it. Police in Esbjerg are investigating an extensive case involving fake OxyContin 80 mg tablets stamped with the correct markings but filled with etonitazene. According to South Jutland police, the risk of overdose from these tablets is extremely high.
The fake OxyContin blister packs look convincing. They carry the Mundipharma label and are packaged as 10-tablet strips. The Danish Health Authority warned that anyone who has bought these pills outside a licensed pharmacy or hospital should not take them. Senior consultant Jacob Møller Antonsen stated that nitazenes can be up to a hundred times stronger than morphine, making the tablets life-threatening.
Why people take the risk
Demand for GLP-1 medicines in Denmark has repeatedly outpaced supply since their launch. Waiting lists grow while out-of-pocket costs remain high for many patients not covered by public reimbursement. For expats still figuring out the Danish healthcare system, navigating GP referrals and insurance rules can feel opaque. Some turn to grey-market suppliers who advertise on social media or through gyms and beauty clinics.
I have watched the gap widen between official capacity and public demand. The system works well if you fit the criteria and know how to use it. But strict eligibility thresholds and regional differences leave people looking for shortcuts. Criminal networks have noticed and adapted their business models accordingly.
What you need to know
The Danish Health Authority is clear: only use prescription medicines prescribed by a Danish doctor and dispensed by a licensed pharmacy or hospital. There is no risk of receiving counterfeit drugs through official channels. As reported by the agency, the danger lies entirely in black-market purchases, whether from websites, social media contacts or unofficial resellers.
If you suspect you have taken counterfeit medicine or experience unusual symptoms, call 112 in an emergency or contact your GP immediately. Patients who have obtained pills or pens outside the official system are urged to hand them over to a pharmacy or police rather than risk using them. In cases of suspected opioid poisoning, naloxone and ventilation are needed, but this must be handled by medical professionals.
The European Medicines Agency has warned since 2023 about falsified Ozempic pens across the EU. Novo Nordisk has filed lawsuits against sellers of illegal copycat products in multiple countries. For Denmark, where the company is a flagship exporter, the stakes are both economic and reputational. But the core issue remains clinical. People are dying from medicines that are not medicines at all. The safest route is still the slowest: your GP, a proper prescription and a trip to the apotek.
